+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Latin America Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics), By Service Provider (Hospital-based Laboratories), By Application, By Country, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 125 Pages
  • June 2023
  • Region: Latin America
  • Grand View Research
  • ID: 4479718
Description Jump to:
The Latin America clinical laboratory services market size is expected to reach USD 17.59 billion by 2030, expanding at a CAGR of 3.6% from 2023 to 2030, according to this report. Increase in disease prevalence and high demand for early disease diagnosis are expected to boost the market in the coming years. These factors have prompted market players to introduce innovative services to address the growing demand.

The introduction of accurate and technologically advanced products, such as biochips, microarrays, and companion diagnostics has increased the demand for early disease detection. This is mainly due to a rising healthcare expenditure owing to an increasing prevalence of chronic diseases. For instance, biochips are used for preparing thousands of DNA, RNA, or protein samples, which can be processed at the same time on a single chip. Products such as companion diagnostics also reduce the overall healthcare cost by helping physicians identify the most suitable treatment option based on the genetic makeup of a patient.

The entry of novel technologies such as automated instruments, high throughput analyzers, and multiplex diagnostic cassettes has improved the diagnostic capacity of laboratories such as Diagnósticos da América SA (DASA) to over 10 million tests a day. Moreover, in July 2022, Beckman Coulter, Inc. announced medical advancements in laboratory solutions at the 2022 AACC Clinical Lab Expo, which helps in enhancing productivity, streamlining workflows, and bringing automation to labs of all sizes.

There has been an increase in the number of hospitals providing laboratory services and facilities providing standalone services. Key players are actively involved in strategic alliances and mergers & acquisitions to enhance their market presence, leading to strong competitive rivalry. The market is price-sensitive, and therefore, players can be increasingly competitive when it comes to manufacturing cost-effective & efficient products. However, owing to the COVID-19 pandemic, the need to manage COVID-19 has increased regulatory approvals of tests, which is expected to create lucrative opportunities..

Latin America Clinical Laboratory Servies Market Report Highlights

  • In 2022, the clinical chemistry segment dominated the Latin America clinical laboratory services market owing to increasing demand for early cancer screening due to the rising of cancer
  • The hospital-based laboratories segment held the largest share in 2022 as these laboratories cater to a large patient pool for different types of testing services
  • The bioanalytical and lab chemistry services segment is the highest revenue-generating segment in 2022 attributed to increasing number of investigational drugs undergoing clinical trials
  • The Latin America clinical laboratory services market has seen unprecedented growth due to the introduction of innovative services to address the growing demands
  • Brazil dominated the Latin America clinical laboratory services market in 2022 attributed to relatively advanced healthcare infrastructure, a high prevalence of infectious & chronic diseases, and an increase in laboratory automation rate
  • Mexico is expected to witness the fastest growth during the forecast period. The high number of tests being conducted in the country is expected to create opportunities for market growth

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Market Definitions
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Secondary Sources
1.4.3 Primary Research
1.4.4 Details Of Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom-Up Approach
1.8 Regional Market: Cagr Calculation
1.9 Research Assumptions
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
1.12 Objectives
1.12.1 Objective 1:
1.12.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Test Type And Service Provider Segment Snapshot
2.3 Application Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Latin America Clinical Laboratory Services Market Variables, Trends, And Scope
3.1 Clinical Laboratory Services Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Technological Advancements In The Field Of Clinical Testing
3.2.1.2 Growing Prevalence Of Target Diseases And Rising Demand For Early Disease Diagnostic Tests
3.2.1.3 Introduction Of Novel Solutions
3.2.1.4 Outbreak Of Covid-19
3.2.2 Market Restraint Analysis
3.2.2.1 Presence Of Ambiguous Regulatory Framework
3.2.2.2 Introduction Of Novel Solutions & Home Health Tests
3.3 Clinical Laboratory Services Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Macroeconomic Analysis
Chapter 4 Latin America Clinical Laboratory Services Market: Segment Analysis, By Test Type, 2018 - 2030 (Usd Billion)
4.1 Latin America Clinical Laboratory Services Market: Test Type Movement Analysis
4.2 Latin America Clinical Laboratory Services Market Estimates & Forecast, By Test Type (Usd Billion)
4.2.1 Human & Tumor Genetics Tests
4.2.2 Clinical Chemistry Tests
4.2.3 Medical Microbiology & Cytology Tests
4.2.4 Other Esoteric Tests
Chapter 5 Latin America Clinical Laboratory Services Market: Segment Analysis, By Service Provider, 2018 - 2030 (Usd Billion)
5.1 Latin America Clinical Laboratory Services Market: Service Provider Movement Analysis
5.2 Latin America Clinical Laboratory Services Market Estimates & Forecast, By Service Provider (Usd Billion)
5.2.1 Hospital-Based Laboratories
5.2.2 Standalone Laboratories
5.2.3 Clinic-Based Laboratories
Chapter 6 Latin America Clinical Laboratory Services Market: Segment Analysis, By Application, 2018 - 2030 (Usd Billion)
6.1 Latin America Clinical Laboratory Services Market: Application Movement Analysis
6.2 Latin America Clinical Laboratory Services Market Estimates & Forecast, By Application (Usd Billion)
6.2.1 Bioanalytical & Lab Chemistry Services
6.2.2 Toxicology Testing Services
6.2.3 Cell & Gene Therapy Related Services
6.2.4 Preclinical & Clinical Trial Related Services
6.2.5 Drug Discovery & Development Related Services
6.2.6 Other Clinical Laboratory Services
Chapter 7 Latin America Clinical Laboratory Services Market Regional Outlook
7.1 Latin America
7.1.1 Latin America Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.2 Brazil
7.1.2.1 Key Country Dynamics
7.1.2.2 Cancer Burden In Brazil
7.1.2.3 Brazil Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.2.4 Market And Competitive Scenario
7.1.2.5 Regulatory Framework
7.1.2.6 Reimbursement Scenario
7.1.3 Mexico
7.1.3.1 Key Country Dynamics
7.1.3.2 Cancer Burden In Mexico
7.1.3.3 Mexico Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.3.4 Market And Competitive Scenario
7.1.3.5 Regulatory Framework
7.1.3.6 Reimbursement Scenario
7.1.4 Argentina
7.1.4.1 Key Country Dynamics
7.1.4.2 Cancer Burden In Argentina
7.1.4.3 Argentina Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.4.4 Market And Competitive Scenario
7.1.4.5 Regulatory Framework
7.1.4.6 Reimbursement Scenario
7.1.5 Colombia
7.1.5.1 Key Country Dynamics
7.1.5.2 Cancer Burden In Colombia
7.1.5.3 Colombia Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.5.4 Market And Competitive Scenario
7.1.5.5 Regulatory Framework
7.1.5.6 Reimbursement Scenario
7.1.6 Peru
7.1.6.1 Key Country Dynamics
7.1.6.2 Cancer Burden In Peru
7.1.6.3 Peru Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.6.4 Market And Competitive Scenario
7.1.6.5 Regulatory Framework & Reimbursement Scenario
7.1.7 Chile
7.1.7.1 Key Country Dynamics
7.1.7.2 Cancer Burden In Chile
7.1.7.3 Chile Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.7.4 Market And Competitive Scenario
7.1.7.5 Regulatory Framework & Reimbursement Scenario
7.1.8 Uruguay
7.1.8.1 Key Country Dynamics
7.1.8.2 Cancer Burden In Uruguay
7.1.8.3 Uruguay Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.8.4 Market And Competitive Scenario
7.1.8.5 Regulatory Framework & Reimbursement Scenario
7.1.9 Dominican Republic
7.1.9.1 Key Country Dynamics
7.1.9.2 Incidence And Mortality Rates Of Top 10 Cancers In Dominican Republic
7.1.9.3 Dominican Republic Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.9.4 Market And Competitive Scenario
7.1.9.5 Regulatory Framework & Reimbursement Scenario
7.1.10 Costa Rica
7.1.10.1 Key Country Dynamics
7.1.10.2 Cancer Burden In Costa Rica
7.1.10.3 Costa Rica Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.10.4 Market And Competitive Scenario
7.1.10.5 Regulatory Framework & Reimbursement Scenario
7.1.11 Panama
7.1.11.1 Key Country Dynamics
7.1.11.2 Cancer Burden In Panama
7.1.11.3 Panama Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
7.1.11.4 Market And Competitive Scenario
7.1.11.5 Regulatory Framework & Reimbursement Scenario
7.1.12 Rest Of Latin America Clinical Laboratory Services Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 8 Competitive Landscape
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 New product launch
8.2.2 Partnerships
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 ABBOTT
8.4.1.1 Company Overview
8.4.1.2 Financial Performance
8.4.1.3 Product Benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 OPKO HEALTH, INC.
8.4.2.1 Company Overview
8.4.2.2 Financial Performance
8.4.2.3 Product Benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 FRESENIUS MEDICAL CARE AG & CO. KGAA
8.4.3.1 Company Overview
8.4.3.2 Financial Performance
8.4.3.3 Product Benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 QIAGEN
8.4.4.1 Company Overview
8.4.4.2 Financial Performance
8.4.4.3 Product Benchmarking
8.4.4.4 Strategic Initiatives
8.4.5 QUEST DIAGNOSTICS INCORPORATED
8.4.5.1 Company Overview
8.4.5.2 Financial Performance
8.4.5.3 Product Benchmarking
8.4.5.4 Strategic Initiatives
8.4.6 SIEMENS HEALTHCARE GMBH
8.4.6.1 Company Overview
8.4.6.2 Financial Performance
8.4.6.3 Product Benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 CHARLES RIVER LABORATORIES
8.4.7.1 Company Overview
8.4.7.2 Financial Performance
8.4.7.3 Product Benchmarking
8.4.7.4 Strategic Initiatives
8.4.8 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
8.4.8.1 Company Overview
8.4.8.2 Financial Performance
8.4.8.3 Product Benchmarking
8.4.8.4 Strategic Initiatives
8.4.9 DAVITA INC.
8.4.9.1 Company Overview
8.4.9.2 Financial Performance
8.4.9.3 Product Benchmarking
8.4.9.4 Strategic Initiatives
8.4.10 SYSMEX CORPORATION
8.4.10.1 Company Overview
8.4.10.2 Financial Performance
8.4.10.3 Product Benchmarking
8.4.10.4 Strategic Initiatives
8.4.11 MYRIAD GENETICS, INC.
8.4.11.1 Company Overview
8.4.11.2 Financial Performance
8.4.11.3 Product Benchmarking
8.4.11.4 Strategic Initiatives
8.4.12 GENOMIC HEALTH (EXACT SCIENCES CORPORATION)
8.4.12.1 Company Overview
8.4.12.2 Financial Performance
8.4.12.3 Product Benchmarking
8.4.12.4 Strategic Initiatives
8.4.13 DASA
8.4.13.1 Company Overview
8.4.13.2 Financial Performance
8.4.13.3 Product Benchmarking
8.4.13.4 Strategic Initiatives
Chapter 9 Conclusion
List of Tables
Table 1: List of Secondary Sources
Table 2: List of Reimbursement Rate for Laboratory Tests
Table 3: List of Key Service Providers
Table 4: Medicare Payments for Clinical Laboratory Tests
Table 5: Leading Market Players Anticipated to Witness Highest Growth
Table 6: Latin America Clinical Laboratory Services Market, By Country, 2018-2030 (USD Billion)
Table 7: Latin America Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 8: Latin America Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 9: Latin America Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 10: Brazil Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 11: Brazil Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 12: Brazil Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 13: Mexico Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 14: Mexico Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 15: Mexico Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 16: Argentina Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 17: Argentina Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 18: Argentina Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 19: Colombia Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 20: Colombia Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 21: Colombia Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 22: Peru Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 23: Peru Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 24: Peru Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 25: Chile Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 26: Chile Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 27: Chile Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 28: Uruguay Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 29: Uruguay Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 30: Uruguay Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 31: Dominican Republic Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 32: Dominican Republic Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 33: Dominican Republic Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 34: Costa Rica Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 35: Costa Rica Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 36: Costa Rica Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
Table 37: Panama Clinical Laboratory Services Market, By Test Type, 2018-2030 (USD Billion)
Table 38: Panama Clinical Laboratory Services Market, By Service Provider, 2018-2030 (USD Billion)
Table 39: Panama Clinical Laboratory Services Market, By Application, 2018-2030 (USD Billion)
List of Figures
Fig. 1: Latin America clinical laboratory services market segmentation
Fig. 2: Market research process
Fig. 3: Information procurement
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value-chain-based sizing & forecasting
Fig. 7: QFD modeling for market share assessment
Fig. 8: Market formulation & validation
Fig. 9: Market outlook (2022)
Fig. 10: Penetration & growth prospect mapping
Fig. 11: Market driver relevance analysis (Current & future impact)
Fig. 12: Diabetes prevalence by countries in the age group of 20 to 79 years
Fig. 13: Current and projected prevalence of diabetes, by country, 2013 & 2035 (% increase)
Fig. 14: Market restrain relevance analysis (Current & future impact)
Fig. 15: Porter’s five forces analysis
Fig. 16: User perspective analysis
Fig. 17: Incidence (2018)
Fig. 18: Prevalence (2018)
Fig. 19: Latin America clinical laboratory services market: Test type outlook and key takeaways
Fig. 20: Latin America clinical laboratory services market: Test type movement analysis
Fig. 21: Latin America clinical laboratory services: Test type segment dashboard
Fig. 22: Human & tumor genetics market estimates and forecast, 2018-2030 (USD Billion)
Fig. 23: Clinical chemistry market estimates and forecast, 2018-2030 (USD Billion)
Fig. 24: Medical microbiology & cytology market estimates and forecast, 2018-2030 (USD Billion)
Fig. 25: Other esoteric tests market estimates and forecast, 2018-2030 (USD Billion)
Fig. 26: Latin America clinical laboratory services market: Service provider outlook and key takeaways
Fig. 27: Latin America clinical laboratory services market: Service provider movement analysis
Fig. 28: Latin America clinical laboratory services: Service provider segment dashboard
Fig. 29: Hospital-based laboratories market estimates and forecast, 2018-2030 (USD Billion)
Fig. 30: Stand-alone laboratories market estimates and forecast, 2018-2030 (USD Billion)
Fig. 31: Clinic-based laboratories market estimates and forecast, 2018-2030 (USD Billion)
Fig. 32: Latin America clinical laboratory services market: Application outlook and key takeaways
Fig. 33: Latin America clinical laboratory services market: Application movement analysis
Fig. 34: Latin America clinical laboratory services: Application segment dashboard
Fig. 35: Bioanalytical & lab chemistry services market estimates and forecast, 2018-2030 (USD Billion)
Fig. 36: Toxicology testing services market estimates and forecast, 2018-2030 (USD Billion)
Fig. 37: Cell & gene therapy related services market estimates and forecast, 2018-2030 (USD Billion)
Fig. 38: Preclinical & clinical trial related services market estimates and forecast, 2018-2030 (USD Billion)
Fig. 39: Drug discovery & development related services market estimates and forecast, 2018-2030 (USD Billion)
Fig. 40: Others market estimates and forecast, 2018-2030 (USD Billion)
Fig. 41: Regional outlook, 2022 & 2030
Fig. 42: Regional market dashboard
Fig. 43: Regional market place: Key takeaways
Fig. 44: Latin America
Fig. 45: Latin America clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 46: Brazil key country dynamics
Fig. 47: Brazil clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 48: Mexico key country dynamics
Fig. 49: Mexico clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 50: Argentina key country dynamics
Fig. 51: Argentina clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 52: Colombia key country dynamics
Fig. 53: Colombia clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 54: Peru key country dynamics
Fig. 55: Peru clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 56: Chile key country dynamics
Fig. 57: Chile clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 58: Uruguay key country dynamics
Fig. 59: Uruguay clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 60: Dominican Republic key country dynamics
Fig. 61: Dominican Republic clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 62: Costa Rica key country dynamics
Fig. 63: Costa Rica clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 64: Panama key country dynamics
Fig. 65: Panama clinical laboratory services market, 2018-2030 (USD Billion)
Fig. 66: Strategy framework
Fig. 67: Participant categorization
Fig. 68: Ansoff matrix
Fig. 69: Market differentiators

Companies Mentioned

  • ABBOTT
  • OPKO HEALTH, INC.
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • QIAGEN
  • QUEST DIAGNOSTICS INCORPORATED
  • SIEMENS HEALTHCARE GMBH
  • CHARLES RIVER LABORATORIES
  • LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
  • DAVITA INC.
  • SYSMEX CORPORATION
  • MYRIAD GENETICS, INC.
  • GENOMIC HEALTH (EXACT SCIENCES CORPORATION)
  • DASA

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages125
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 12.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.59 Billion
Compound Annual Growth Rate3.6%
Regions CoveredLatin America
No. of Companies Mentioned13

Related Topics

Related Reports

Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry), By Service Provider, By Application, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry), By Service Provider, By Application, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Global Clinical Laboratory Tests Market Size, Share & Trends Analysis Report by Type (Complete Blood Count, HGB/HCT Testing), End-use (Primary Clinics, Central Laboratories), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Clinical Laboratory Tests Market Size, Share & Trends Analysis Report by Type (Complete Blood Count, HGB/HCT Testing), End-use (Primary Clinics, Central Laboratories), Region, and Segment Forecasts, 2024-2030

  • Report
  • 104 Pages
  • Global
From
Clinical Laboratory Services - Global Strategic Business Report - Product Image

Clinical Laboratory Services - Global Strategic Business Report

  • Report
  • 494 Pages
  • Global
From
Global Clinical Laboratory Tests Market by Test Type (Basic Metabolic Panel, Complete Blood Count, Comprehensive Metabolic Panel), Indication (Autoimmune Diseases, Cardiovascular Diseases, Genetic Disorders), End-User - Forecast 2024-2030 - Product Image

Global Clinical Laboratory Tests Market by Test Type (Basic Metabolic Panel, Complete Blood Count, Comprehensive Metabolic Panel), Indication (Autoimmune Diseases, Cardiovascular Diseases, Genetic Disorders), End-User - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Global Clinical Laboratory Services Market by Provider (Hospital-Based Laboratories, Independent & Reference Laboratories, Nursing & Physician Office-Based Laboratories), Speciality (Clinical Chemistry Testing, Cytology Testing, Drugs of Abuse Testing) - Forecast 2024-2030 - Product Image

Global Clinical Laboratory Services Market by Provider (Hospital-Based Laboratories, Independent & Reference Laboratories, Nursing & Physician Office-Based Laboratories), Speciality (Clinical Chemistry Testing, Cytology Testing, Drugs of Abuse Testing) - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From

About the Clinical Laboratory Market

The Clinical Laboratory market is a segment of the Diagnostics industry that focuses on the analysis of biological samples to detect and diagnose diseases. Clinical laboratories use a variety of techniques, such as immunoassays, flow cytometry, and molecular diagnostics, to identify and quantify the presence of disease markers in patient samples. Clinical laboratories are typically found in hospitals, clinics, and other healthcare facilities, and are staffed by medical technologists and other laboratory personnel. The Clinical Laboratory market is an important part of the Diagnostics industry, as it provides the data necessary for physicians to make informed decisions about patient care. Clinical laboratories are also used to monitor the effectiveness of treatments and to detect the emergence of new diseases. Notable companies in the Clinical Laboratory market include Quest Diagnostics, LabCorp, Sonic Healthcare, Eurofins Scientific, and Bio-Reference Laboratories. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.